Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Annotation |
---|---|---|---|---|---|---|
MligTC455_20178 | 15 | 0.31 | Mlig455_053660 | Neo: - Age: - |
Mlig455_053660 {REF} {Length: 922} {Pfam: LegC3 N-terminal coiled-coil domain [PF18654.3, score=18.5]} {RNA1310_88410} |
Region | logFC | logCPM | Pvalue | FDR | Specificity |
---|---|---|---|---|---|
RegionR1 | -2.241 | 0.701 | 0.99979 | 1.00000 | |
RegionR2 | 0.953 | 0.701 | 1.00000 | 1.00000 | |
RegionR3 | -0.985 | 0.701 | 0.99991 | 1.00000 | |
RegionR4 | 1.732 | 0.701 | 0.03669 | 0.15650 | |
RegionR5 | -0.215 | 0.701 | 1.00000 | 1.00000 | |
RegionR6 | 0.017 | 0.701 | 0.62337 | 1.00000 | |
RegionR7 | 1.412 | 0.701 | 0.99964 | 1.00000 | |
RegionR8 | -0.672 | 0.701 | 0.99999 | 1.00000 |
Region | logFC | logCPM | PValue | FDR | Specificity |
---|---|---|---|---|---|
RegenerationR1 | -0.61 | 0.701 | 0.99994 | 1.00000 | |
RegenerationR2 | -0.599 | 0.701 | 0.23898 | 0.68654 | |
RegenerationR3 | 0.676 | 0.701 | 0.33994 | 0.76428 | |
RegenerationR4 | -3.155 | 0.701 | 0.05679 | 0.38217 | |
RegenerationR5 | 0.165 | 0.701 | 0.99989 | 1.00000 | |
RegenerationR6 | -2.782 | 0.701 | 0.19197 | 0.53073 | |
RegenerationBL | -3.008 | 0.701 | 0.99993 | 1.00000 | |
RegenerationTP | -2.532 | 0.701 | 0.99994 | 1.00000 |
Nr. | Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Σ Spearman correlations | Int1 | Int2 | Int3 | Reg1 | Reg2 | Reg3 | Annotation |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1. | MligTC455_20178 | 15 | 0.31 | Mlig455_053660 | Neo: - Age: - |
2 | - | - | 1.000 | - | 1.000 | - | Mlig455_053660 {REF} {Length: 922} {Pfam: LegC3 N-terminal coiled-coil domain [PF18654.3, score=18.5]} {RNA1310_88410} | |
2. | MligTC455_31210 | 51 | 1.07 | Mlig455_028581 | Neo: - Age: Down-Up-Down |
KCNH7 | 1.808 | - | - | 0.850 | - | 0.958 | - | Mlig455_028581 {REF} {Length: 6310} {Pfam: Ion transport protein [PF00520.33, score=119.1]; PAS domain [PF13426.9, score=52.9]; Ion channel [PF07885.18, score=45.3]; Cyclic nucleotide-binding domain [PF00027.31, score=45.2]; PAS fold [PF00989.27, score=31.5]; PAS fold [PF08447.14, score=26.5]} {Human: ENSG00000184611, KCNH7, potassium voltage-gated channel subfamily H member 7, [RH, Score=820, Expect=0.0]; ENSG00000173826, KCNH6, potassium voltage-gated channel subfamily H member 6, [RH, Score=810, Expect=0.0]; ENSG00000055118, KCNH2, potassium voltage-gated channel subfamily H member 2, [RH, Score=808, Expect=0.0]} {Mouse: ENSMUSG00000059742, Kcnh7, potassium voltage-gated channel, subfamily H (eag-related), member 7, [RH, Score=820, Expect=0.0]; ENSMUSG00000038319, Kcnh2, potassium voltage-gated channel, subfamily H (eag-related), member 2, [RH, Score=808, Expect=0.0]; ENSMUSG00000001901, Kcnh6, potassium voltage-gated channel, subfamily H (eag-related), member 6, [RH, Score=806, Expect=0.0]} {Dmel: FBgn0003353, sei, seizure, [RH, Score=766, Expect=0.0]} {Celegans: WBGene00006830, unc-103, Potassium voltage-gated channel unc-103, [RH, Score=746, Expect=0.0]} {Smed: dd_Smed_v6_12621_0_1, dd_Smed_v6_12621_0_1, [Score=793, Expect=0.0]} {RNA1509_40124} {RNA1310_20497} {RNA815_15478} |
3. | MligTC455_44851 | 243 | 5.06 | Mlig455_005343, Mlig455_005452, Mlig455_005455 | Neo: - Age: - Regeneration-upregulated BL: 5.289 Regeneration-enriched BL: 5.289 |
0.981 | - | - | 0.981 | - | - | - | Mlig455_005343 {REF} {Length: 922} {NoTransDecoderORF} {RNA1310_11820} Mlig455_005452 {REF} {Length: 544} {NoTransDecoderORF} {RNA1310_11820} Mlig455_005455 {REF} {Length: 345} {NoTransDecoderORF} {RNA1310_11820} |
|
4. | MligTC455_24515 | 14 | 0.28 | Mlig455_033346, Mlig455_033365 | Neo: - Age: - |
HTR1B | 0.975 | - | - | - | - | 0.975 | - | Mlig455_033346 {REF} {Length: 1493} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=216.8]; Serpentine type 7TM GPCR chemoreceptor Srx [PF10328.11, score=27.3]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=23.5]} {Human: ENSG00000135312, HTR1B, 5-hydroxytryptamine receptor 1B, [Score=211, Expect=4e-63]} {Mouse: ENSMUSG00000021478, Drd1, dopamine receptor D1, [RH, Score=189, Expect=2e-54]} {Dmel: FBgn0004573, 5-HT7, 5-hydroxytryptamine (serotonin) receptor 7, [Score=182, Expect=7e-51]} {Celegans: WBGene00001052, dop-1, DOPamine receptor, [Score=176, Expect=4e-50]} {Smed: dd_Smed_v6_26479_0_1, dd_Smed_v6_26479_0_1, [Score=218, Expect=5e-66]} {RNA1310_132724} Mlig455_033365 {REF} {Length: 1935} {TRANSSPLICED} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=216.2]; Serpentine type 7TM GPCR chemoreceptor Srx [PF10328.11, score=25.9]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=24.0]} {Human: ENSG00000135312, HTR1B, 5-hydroxytryptamine receptor 1B, [Score=211, Expect=7e-63]} {Mouse: ENSMUSG00000021478, Drd1, dopamine receptor D1, [RH, Score=191, Expect=4e-55]} {Dmel: FBgn0004573, 5-HT7, 5-hydroxytryptamine (serotonin) receptor 7, [Score=182, Expect=7e-51]} {Celegans: WBGene00001052, dop-1, DOPamine receptor, [Score=178, Expect=8e-51]} {Smed: dd_Smed_v6_26479_0_1, dd_Smed_v6_26479_0_1, [Score=216, Expect=2e-65]} {RNA1310_132724} |
5. | MligTC455_06989 | 68 | 1.42 | Mlig455_026846 | Neo: - Age: - |
0.964 | - | - | 0.964 | - | - | - | Mlig455_026846 {REF} {Length: 573} {NoTransDecoderORF} {RNA1509_59553} {RNA1310_127391} | |
6. | MligTC455_49214 | 6 | 0.13 | Mlig455_068565 | Neo: - Age: - |
0.963 | - | - | - | - | 0.963 | - | Mlig455_068565 {REF} {Length: 1544} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=105.5]} {Smed: dd_Smed_v6_26469_0_1, dd_Smed_v6_26469_0_1, [Score=53.1, Expect=3e-08]} {RNA1310_27155} {RNA815_39321} | |
7. | MligTC455_53809 | 608 | 12.67 | Mlig455_063377 | Neo: - Age: logFC(26M/2M)=-0.339 |
HUNK | 0.963 | - | - | - | - | 0.963 | - | Mlig455_063377 {REF} {Length: 4517} {Pfam: Protein kinase domain [PF00069.27, score=241.4]; Protein tyrosine and serine/threonine kinase [PF07714.19, score=147.5]; Lipopolysaccharide kinase (Kdo/WaaP) family [PF06293.16, score=25.3]; Kinase-like [PF14531.8, score=24.3]; RIO1 family [PF01163.24, score=19.0]; Haspin like kinase domain [PF12330.10, score=18.0]} {Human: ENSG00000142149, HUNK, hormonally up-regulated Neu-associated kinase, [RH, Score=382, Expect=1e-120]} {Mouse: ENSMUSG00000053414, Hunk, hormonally upregulated Neu-associated kinase, [RH, Score=385, Expect=1e-121]} {Dmel: FBgn0023169, AMPKalpha, AMP-activated protein kinase alpha subunit, [Score=218, Expect=4e-61]} {Celegans: WBGene00003916, par-1, Serine/threonine-protein kinase par-1, [Score=226, Expect=2e-61]} {Smed: dd_Smed_v6_2538_0_1, dd_Smed_v6_2538_0_1, [Score=223, Expect=1e-63]} {RNA1509_10302, RNA1509_25913} {RNA1310_5970, RNA1509_10302, RNA1509_25913} {RNA1509_10302, RNA1509_25913, RNA815_9514} |
8. | MligTC455_14124 | 9 | 0.19 | Mlig455_004227, Mlig455_031052, Mlig455_031059 | Neo: - |
OTOGL, SSPO | 0.961 | - | - | - | - | 0.961 | - | Mlig455_004227 {REF} {Length: 8347} {Pfam: von Willebrand factor type D domain [PF00094.27, score=218.9]; C8 domain [PF08742.13, score=94.5]; Low-density lipoprotein receptor domain class A [PF00057.20, score=62.7]; Trypsin Inhibitor like cysteine rich domain [PF01826.19, score=52.1]} {Human: ENSG00000197558, SSPO, SCO-spondin, [Score=506, Expect=2e-143]} {Mouse: ENSMUSG00000029797, Sspo, SCO-spondin, [Score=499, Expect=2e-141]} {Dmel: FBgn0029167, Hml, Hemolectin, [Score=327, Expect=5e-89]} {Celegans: WBGene00020481, T13C2.6, [Score=107, Expect=5e-23]} {Smed: dd_Smed_v6_9342_0_1, dd_Smed_v6_9342_0_1, [Score=1126, Expect=0.0]} {RNA1509_11979, RNA1509_44751} {RNA1310_598, RNA1509_44751} {RNA1509_44751, RNA815_582} Mlig455_031052 {REF} {Length: 3393} {Pfam: von Willebrand factor type D domain [PF00094.27, score=117.0]; C8 domain [PF08742.13, score=60.4]; Trypsin Inhibitor like cysteine rich domain [PF01826.19, score=40.8]} {Human: ENSG00000165899, OTOGL, otogelin like, [Score=200, Expect=1e-51]} {Mouse: ENSMUSG00000001930, Vwf, Von Willebrand factor, [Score=200, Expect=8e-52]; ENSMUSG00000091455, Otogl, otogelin-like, [Score=196, Expect=1e-50]} {Dmel: FBgn0029167, Hml, Hemolectin, [Score=149, Expect=4e-36]} {Smed: dd_Smed_v6_9342_0_1, dd_Smed_v6_9342_0_1, [Score=497, Expect=7e-154]} {RNA1509_47011} {RNA1310_598} {RNA815_582} Mlig455_031059 {REF} {Length: 5292} {Pfam: von Willebrand factor type D domain [PF00094.27, score=221.4]; C8 domain [PF08742.13, score=99.8]; Trypsin Inhibitor like cysteine rich domain [PF01826.19, score=55.1]; Low-density lipoprotein receptor domain class A [PF00057.20, score=52.2]} {Human: ENSG00000197558, SSPO, SCO-spondin, [Score=489, Expect=4e-142]} {Mouse: ENSMUSG00000029797, Sspo, SCO-spondin, [Score=488, Expect=6e-142]} {Dmel: FBgn0029167, Hml, Hemolectin, [Score=322, Expect=1e-88]} {Celegans: WBGene00003071, lrp-1, Low-density lipoprotein receptor-related protein, [Score=74.7, Expect=6e-13]} {Smed: dd_Smed_v6_9342_0_1, dd_Smed_v6_9342_0_1, [Score=1061, Expect=0.0]} {RNA1509_47011} {RNA1310_598} {RNA815_582} |
9. | MligTC455_50608 | 54 | 1.12 | Mlig455_052081 | Neo: - Age: - |
0.96 | - | - | 0.960 | - | - | - | Mlig455_052081 {REF} {Length: 1078} {NoTransDecoderORF} {RNA1509_6638} {RNA1310_37389} {RNA815_17670.2} | |
10. | MligTC455_33875 | 32 | 0.67 | Mlig455_039631 | Neo: - Age: - |
0.956 | - | - | - | - | 0.956 | - | Mlig455_039631 {REF} {Length: 3055} {TRANSSPLICED} {RNA1509_14655, RNA1509_53977} {RNA1310_22046.1, RNA1509_53977} {RNA1509_53977, RNA815_8738} | |
11. | MligTC455_07507 | 360 | 7.51 | Mlig455_040982, Mlig455_056397 | Neo: - Age: - Region-enriched R2: 2.117/0.00410 |
NOS1AP | 0.955 | - | - | 0.955 | - | - | - | Mlig455_040982 {REF} {Length: 4127} {TRANSSPLICED} {Pfam: Phosphotyrosine interaction domain (PTB/PID) [PF00640.25, score=82.3]} {Human: ENSG00000198929, NOS1AP, nitric oxide synthase 1 adaptor protein, [Score=246, Expect=5e-72]} {Mouse: ENSMUSG00000038473, Nos1ap, nitric oxide synthase 1 (neuronal) adaptor protein, [RH, Score=243, Expect=6e-71]} {Dmel: FBgn0261555, CG42673, [RH, Score=207, Expect=1e-56]} {Celegans: WBGene00001116, dyc-1, Dystrophin-like protein 1, [RH, Score=238, Expect=2e-66]} {Smed: dd_Smed_v6_13377_0_1, dd_Smed_v6_13377_0_1, [RH, Score=237, Expect=1e-68]} {RNA1509_50976} {RNA1310_3831} {RNA815_14327} Mlig455_056397 {REF} {Length: 4127} {TRANSSPLICED} {Pfam: Phosphotyrosine interaction domain (PTB/PID) [PF00640.25, score=82.3]} {Human: ENSG00000198929, NOS1AP, nitric oxide synthase 1 adaptor protein, [Score=246, Expect=5e-72]} {Mouse: ENSMUSG00000038473, Nos1ap, nitric oxide synthase 1 (neuronal) adaptor protein, [RH, Score=243, Expect=4e-71]} {Dmel: FBgn0261555, CG42673, [RH, Score=207, Expect=1e-56]} {Celegans: WBGene00001116, dyc-1, Dystrophin-like protein 1, [RH, Score=238, Expect=2e-66]} {Smed: dd_Smed_v6_13377_0_1, dd_Smed_v6_13377_0_1, [RH, Score=237, Expect=1e-68]} {RNA1509_50976} {RNA1310_3831} {RNA815_14327} |
12. | MligTC455_10204 | 14 | 0.29 | Mlig455_049702, Mlig455_049708 | Neo: - Age: - |
0.955 | - | - | - | - | 0.955 | - | Mlig455_049702 {REF} {Length: 217} {NoTransDecoderORF} {RNA1509_48455} {RNA1310_47324} {RNA815_43123} Mlig455_049708 {REF} {Length: 443} {NoTransDecoderORF} {RNA1509_48455} {RNA1310_57782} {RNA815_43123} |
|
13. | MligTC455_23788 | 70 | 1.47 | Mlig455_001520 | Neo: - Age: - |
0.955 | - | - | 0.955 | - | - | - | Mlig455_001520 {REF} {Length: 600} {NoTransDecoderORF} {RNA1310_15822} {RNA815_34166} | |
14. | MligTC455_05979 | 11 | 0.23 | Mlig455_067718 | Neo: - Age: - |
0.954 | - | - | - | - | 0.954 | - | Mlig455_067718 {REF} {Length: 1018} {RNA1509_2330} {RNA1310_37520} {RNA815_22367} | |
15. | MligTC455_51983 | 341 | 7.09 | Mlig455_026114 | Neo: - Age: Up-Down-Up |
0.954 | - | - | - | - | 0.954 | - | Mlig455_026114 {REF} {Length: 3233} {TRANSSPLICED} {Pfam: Ubiquitin-conjugating enzyme [PF00179.28, score=40.1]} {Smed: dd_Smed_v6_3423_0_1, dd_Smed_v6_3423_0_1, [Score=80.9, Expect=6e-18]} {RNA1509_23666} {RNA1310_19234.1, RNA1509_23666} {RNA1509_23666, RNA815_18307} | |
16. | MligTC455_06577 | 7 | 0.14 | Mlig455_044334 | Neo: - Age: Up-Down-Down |
0.953 | - | - | - | - | 0.953 | - | Mlig455_044334 {REF} {Length: 706} | |
17. | MligTC455_15005 | 13 | 0.26 | Mlig455_007503 | Neo: - Age: - |
0.953 | - | - | - | - | 0.953 | - | Mlig455_007503 {REF} {Length: 2488} {Pfam: Immunoglobulin domain [PF13895.8, score=20.5]} {RNA1310_66411} {RNA815_43821} | |
18. | MligTC455_20099 | 15 | 0.32 | Mlig455_037109 | Neo: - Age: - |
0.952 | - | - | - | - | 0.952 | - | Mlig455_037109 {REF} {Length: 817} {NoTransDecoderORF} {RNA1310_30726} {RNA815_35778} | |
19. | MligTC455_33637 | 187 | 3.9 | Mlig455_027211, Mlig455_027458 | Neo: - Age: - Region-enriched R2: 3.458/0.04514 |
CHRNA10, CHRNA7 | 0.951 | - | - | - | - | 0.951 | - | Mlig455_027211 {REF} {Length: 782} {Pfam: Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=71.6]} {Human: ENSG00000175344, CHRNA7, cholinergic receptor nicotinic alpha 7 subunit, [Score=89.4, Expect=4e-20]; ENSG00000129749, CHRNA10, cholinergic receptor nicotinic alpha 10 subunit, [Score=89.4, Expect=4e-20]; ENSG00000166664, CHRFAM7A, CHRNA7 (exons 5-10) and FAM7A (exons A-E) fusion, [Score=89.0, Expect=2e-20]; ENSG00000275917, CHRFAM7A, CHRNA7 (exons 5-10) and FAM7A (exons A-E) fusion, [Score=89.0, Expect=1e-20]; ENSG00000274542, AC243734.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=88.6, Expect=7e-20]; ENSG00000282088, AC254952.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=88.6, Expect=7e-20]} {Mouse: ENSMUSG00000030525, Chrna7, cholinergic receptor, nicotinic, alpha polypeptide 7, [Score=92.0, Expect=4e-21]} {Dmel: FBgn0004118, nAChRbeta2, nicotinic Acetylcholine Receptor beta2, [Score=81.6, Expect=9e-18]} {Celegans: WBGene00000048, acr-9, AcetylCholine Receptor, [Score=71.6, Expect=2e-14]} {Smed: dd_Smed_v6_31300_0_1, dd_Smed_v6_31300_0_1, [Score=86.3, Expect=1e-19]} {RNA1310_19147.2} {RNA815_8553.2} Mlig455_027458 {REF} {Length: 1493} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=93.3]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=71.5]} {Human: ENSG00000129749, CHRNA10, cholinergic receptor nicotinic alpha 10 subunit, [Score=149, Expect=1e-39]} {Mouse: ENSMUSG00000066279, Chrna10, cholinergic receptor, nicotinic, alpha polypeptide 10, [Score=148, Expect=1e-39]} {Dmel: FBgn0004118, nAChRbeta2, nicotinic Acetylcholine Receptor beta2, [Score=133, Expect=5e-34]} {Celegans: WBGene00000048, acr-9, AcetylCholine Receptor, [Score=144, Expect=6e-38]} {Smed: dd_Smed_v6_31300_0_1, dd_Smed_v6_31300_0_1, [Score=144, Expect=7e-38]} {RNA1310_19147.2} {RNA815_8553.2} |
20. | MligTC455_27521 | 681 | 14.19 | Mlig455_050046 | Neo: - Age: Down-Up-Down, logFC(26M/2M)=0.667 Region-enriched R2: 1.375/0.04610 |
ABCG2 | 0.95 | - | - | - | - | 0.950 | - | Mlig455_050046 {REF} {Length: 3109} {Pfam: ABC-2 type transporter [PF01061.26, score=96.6]; ABC transporter [PF00005.29, score=96.0]; ABC-2 type transporter [PF19055.2, score=48.9]; AAA domain, putative AbiEii toxin, Type IV TA system [PF13304.8, score=25.0]} {Human: ENSG00000118777, ABCG2, ATP binding cassette subfamily G member 2 (Junior blood group), [Score=248, Expect=2e-72]} {Mouse: ENSMUSG00000029802, Abcg2, ATP binding cassette subfamily G member 2 (Junior blood group), [Score=249, Expect=4e-73]} {Dmel: FBgn0020445, E23, Early gene at 23, [RH, Score=389, Expect=3e-122]} {Celegans: WBGene00015479, wht-1, ABC transporter ATP-binding protein/permease wht-1, [Score=220, Expect=4e-63]} {Smed: dd_Smed_v6_4081_0_1, dd_Smed_v6_4081_0_1, [RH, Score=222, Expect=4e-63]} {RNA1509_19841, RNA1509_37967, RNA1509_52359} {RNA1310_6299.1, RNA1509_37967, RNA1509_52359} {RNA1509_37967, RNA1509_52359, RNA815_1994.1} |